Carcinoembryonic Antigen (CEA)
Catalogue Number: 151-09
Description
| Product Name | Carcinoembryonic Antigen |
| Source | Human Metastatic Liver Carcinoma |
| Catalogue Number | 151-09 |
| Purity | > 95% (SDS-PAGE) |
| Form | Lyophilized |
| Activity | > 0.9 mg/mg solid (ELISA) |
| Formulation | Lyophilized from 50 mM ammonium bicarbonate. |
| Related Products | 151-10 - Carcinoembryonic Antigen (CEA) from human liver - Liquid 151-12 - anti-Human Carcinoembryonic Antigen (CEA) polyclonal antibody 151-53 - Cancer Antigen 15-3 from human ascites fluid |
| Storage | -20°C |
| Recertification | 5 years |
| Infectious Disease Testing | Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods. |
| Synonyms | CEA, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100, CD_antigen=CD66e |
| Gene | CEACAM5, CD66e, CEA |
| Molecular Weight | ~180,000 |
| Gene ID | 1048 |
| Accession No | P06731 |
Applications
Overview
Lee Biosolutions is a producer and supplier of standard grade human Carcinoembryonic Antigen (CEA), a marker for bowel cancer, colorectal carcinoma, lung cancer research and diagnostic manufacturing.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Associated Cancer Types: Gastrointestinal Cancer Cervix Cancer Lung Cancer Ovarian Cancer Breast Cancer Urinary Tract Cancer 5
Add to Cart
Lee Biosolutions, Inc
